|
| FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter |
3 Jul 09, 12:07 |
|
| Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease. |
| more |
|
